APA (7th ed.) Citation

Chang, E. W. Y., Tan, Y. H., & Chan, J. Y. (2024). Novel clinical risk stratification and treatment strategies in relapsed/refractory peripheral T-cell lymphoma. Journal of hematology and oncology, 17(1), 38-20. https://doi.org/10.1186/s13045-024-01560-7

Chicago Style (17th ed.) Citation

Chang, Esther Wei Yin, Ya Hwee Tan, and Jason Yongsheng Chan. "Novel Clinical Risk Stratification and Treatment Strategies in Relapsed/refractory Peripheral T-cell Lymphoma." Journal of Hematology and Oncology 17, no. 1 (2024): 38-20. https://doi.org/10.1186/s13045-024-01560-7.

MLA (9th ed.) Citation

Chang, Esther Wei Yin, et al. "Novel Clinical Risk Stratification and Treatment Strategies in Relapsed/refractory Peripheral T-cell Lymphoma." Journal of Hematology and Oncology, vol. 17, no. 1, 2024, pp. 38-20, https://doi.org/10.1186/s13045-024-01560-7.